Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Single Institution ◽

Whole Brain Radiation ◽

Dose Methotrexate ◽

Brain Radiation

Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience

Leukemia & Lymphoma ◽

10.3109/10428194.2014.889823 ◽

2014 ◽

Vol 55 (11) ◽

pp. 2497-2501 ◽

Cited By ~ 12

Author(s):

Xiao-xiao Wang ◽

Hui-qiang Huang ◽

Bing Bai ◽

Qing-qing Cai ◽

Qi-chun Cai ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Clinical Outcomes ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Single Institution ◽

Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyx120 ◽

2017 ◽

Vol 47 (11) ◽

pp. 995-1001 ◽

Cited By ~ 1

Author(s):

Jun Su Park ◽

Do Hoon Lim ◽

Yong Chan Ahn ◽

Won Park ◽

Seok Jin Kim ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Radiation Dose ◽

Partial Response ◽

High Dose ◽

High Dose Methotrexate ◽

Whole Brain Radiation ◽

Dose Methotrexate ◽

Brain Radiation

High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma

Leukemia & Lymphoma ◽

10.3109/10428194.2011.584004 ◽

2011 ◽

Vol 52 (10) ◽

pp. 1882-1890 ◽

Cited By ~ 11

Author(s):

Lauren M. Gerard ◽

Kevin R. Imrie ◽

Joy Mangel ◽

Rena Buckstein ◽

Mary Doherty ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience

Oncology Letters ◽

10.3892/ol.2016.4393 ◽

2016 ◽

Vol 11 (5) ◽

pp. 3471-3476 ◽

Cited By ~ 13

Author(s):

K. INA LY ◽

LAURA L. CREW ◽

CARRIE A. GRAHAM ◽

MACIEJ M. MRUGALA

Keyword(s):

Central Nervous System ◽

Nervous System ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma

Journal of Neuro-Oncology ◽

10.1007/s11060-015-1786-1 ◽

2015 ◽

Vol 123 (2) ◽

pp. 237-244 ◽

Cited By ~ 6

Author(s):

Seiichiro Hirono ◽

Yasuo Iwadate ◽

Yoshinori Higuchi ◽

Toru Serizawa ◽

Osamu Nagano ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

High Dose ◽

High Dose Methotrexate ◽

Line Treatment ◽

Newly Diagnosed ◽

First Line ◽

Dose Methotrexate ◽

First Line Treatment

Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study

Cancer Management and Research ◽

10.2147/cmar.s322467 ◽

2021 ◽

Vol Volume 13 ◽

pp. 6115-6122

Author(s):

Qing Li ◽

Jingjing Ma ◽

Yan Ma ◽

Zhiguang Lin ◽

Hui Kang ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Cohort Study ◽

Real World ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

44 High dose methotrexate followed by temozolomide plus concomitant radiation therapy in patients with newly diagnosed primary central nervous system Lymphoma: Preliminary results of a phase I dose escalation study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70715-1 ◽

2010 ◽

Vol 8 (4) ◽

pp. 22-23 ◽

Cited By ~ 1

Author(s):

S. Manfrida ◽

S. Chiesa ◽

L. Teofili ◽

B. Diletto ◽

S. Hohaus ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Radiation Therapy ◽

Phase I ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Dose Escalation Study ◽

Outcome of primary central nervous system lymphoma treated with combined surgical resection and high-dose methotrexate chemotherapy: a single-institution retrospective study

Turkish Neurosurgery ◽

10.5137/1019-5149.jtn.24054-19.2 ◽

2019 ◽

Author(s):

Qiujian Zhang ◽

Dawei Wang ◽

Hansheng Shu

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Retrospective Study ◽

Surgical Resection ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

Dose Methotrexate ◽

Methotrexate Chemotherapy

A phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma

Annals of Oncology ◽

10.1093/annonc/mdy429.004 ◽

2018 ◽

Vol 29 ◽

pp. ix22

Author(s):

N. Adhikari ◽

A. Biswas

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Phase Ii Trial ◽

Whole Brain Radiotherapy ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Brain Radiotherapy ◽

A phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e14088 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e14088-e14088

Author(s):

Narayan Adhikari ◽

Ahitagni Biswas ◽

Ajay Gogia ◽

Ranjit Sahoo ◽

Ajay Garg ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Phase Ii Trial ◽

Whole Brain Radiotherapy ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Brain Radiotherapy ◽